CDC Updates Pneumococcal Vaccine Recommendations

CDC released recommendations for the new 21-Valent Pneumococcal Conjugate Vaccine (PCV-21) for U.S. adults. The Advisory Committee on Immunization Practices (ACIP) recommended PCV21 as an option for adults aged ≥19 years who are currently recommended to receive PCV15 or PCV20. PCV21 contains eight additional serotypes not included in other licensed vaccines.

For full details, read the September 12th MMWR report.

Boosting Senior Vaccination Rates

The American Health Care Association/National Center for Assisted Living (AHCA/NCAL) has launched "#GetVaccinated," a campaign to boost respiratory virus vaccination rates among seniors in care settings. This initiative supplements ongoing nursing home efforts, tackling vaccine fatigue and access challenges. AHCA/NCAL offers a provider checklist, factsheets, and comprehensive resources.

Explore the campaign materials on their website.

NFID Issues Call to Action on Adult Immunization

The National Foundation for Infectious Diseases (NFID) has released a comprehensive "Call to Action" outlining strategies to enhance adult immunization rates in the U.S. This initiative proposes actionable recommendations targeting healthcare systems, providers, patients, and policymakers. The plan offers recommendations aimed at various levels of the healthcare system, focusing on practical approaches to boost adult vaccine uptake.

For detailed information and to access the full report, visit the NFID website.

Stay Informed with CDC’s Respiratory Illnesses Data Channel

The CDC’s Respiratory Illnesses Data Channel offers weekly updates on COVID-19, flu, and RSV activity nationally and by state. This resource helps healthcare providers and the public stay informed about respiratory virus trends as the fall and winter seasons approach.

For more information and the latest data, visit the CDC's Respiratory Illnesses Data Channel.

COVID-19 cases in nursing homes are 8.9 per 1,000 residents as of September 8, yet only 31% are up-to-date on vaccines. CDC recommends the 2024/2025 COVID-19 vaccine for people 6 months and older—visit our WAVE page for resources.

Shot of Knowledge: Vaccine Q&A

Where can I find detailed information about COVID-19 vaccines?

CDC offers a comprehensive "one-stop" webpage for each COVID-19 vaccine, providing essential details for immunization providers. Visit www.cdc.gov/vaccines/covid-19/info-by-product/index.html.



What proof is needed for patients claiming to be moderately or severely immunocompromised?

CDC states that no additional medical documentation is required. The patient's self-affirmation is sufficient, and vaccination should not be denied due to lack of documentation.

For more vaccine FAQs, visit immunize.org. For updated immunization schedules, visit our WAVE page.

Learning & Professional Development